Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Mar;114(3):395-402.
doi: 10.1007/s00702-006-0577-4. Epub 2006 Oct 19.

Is the serotonin transporter polymorphism (5-HTTLPR) associated with harm avoidance and internalising problems in childhood and adolescence?

Affiliations

Is the serotonin transporter polymorphism (5-HTTLPR) associated with harm avoidance and internalising problems in childhood and adolescence?

K Becker et al. J Neural Transm (Vienna). 2007 Mar.

Abstract

The S allele of the 5-HTTLPR has been associated with anxiety-related behavioural traits and harm avoidance. The 5-HTTLPR polymorphism is suggested to modulate the serotonergic response to stress, meaning that individuals carrying the SS genotype who have significant stress histories may tend to develop depressive symptoms. In the Mannheim Study of Risk Children, which followed a cohort of n = 384 from birth to adolescence, the association of 5-HTTLPR with harm avoidance and internalising problems was examined, including gender and early life stress as possible moderators. Child and adolescent characteristics were assessed using the Junior Temperament and Character Inventory, the Child Behaviour Checklist and the Youth Self Report. Early life stress was determined by a risk index measuring the presence of 11 adversity factors. Results did not reveal an association with 5-HTTLPR genotype. There were no moderating effects of early life stress or gender. An explanation for the negative findings is that the S allele may be a necessary but not sufficient component cause in a composite risk factor.

PubMed Disclaimer

References

    1. Int J Epidemiol. 2001 Oct;30(5):1035-40 - PubMed
    1. Science. 2002 Jul 19;297(5580):400-3 - PubMed
    1. Science. 2003 Jul 18;301(5631):386-9 - PubMed
    1. Am J Hum Genet. 2006 May;78(5):815-26 - PubMed
    1. Lancet. 2003 Mar 8;361(9360):865-72 - PubMed

Publication types

MeSH terms

Substances